These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 11285300)

  • 1. A novel mouse model of lipotoxic cardiomyopathy.
    Chiu HC; Kovacs A; Ford DA; Hsu FF; Garcia R; Herrero P; Saffitz JE; Schaffer JE
    J Clin Invest; 2001 Apr; 107(7):813-22. PubMed ID: 11285300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
    Goldenberg JR; Carley AN; Ji R; Zhang X; Fasano M; Schulze PC; Lewandowski ED
    Circulation; 2019 Jun; 139(24):2765-2777. PubMed ID: 30909726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy.
    Chiu HC; Kovacs A; Blanton RM; Han X; Courtois M; Weinheimer CJ; Yamada KA; Brunet S; Xu H; Nerbonne JM; Welch MJ; Fettig NM; Sharp TL; Sambandam N; Olson KM; Ory DS; Schaffer JE
    Circ Res; 2005 Feb; 96(2):225-33. PubMed ID: 15618539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart.
    Yu X; Burgess SC; Ge H; Wong KK; Nassem RH; Garry DJ; Sherry AD; Malloy CR; Berger JP; Li C
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1767-72. PubMed ID: 15659544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages modulate cardiac function in lipotoxic cardiomyopathy.
    Schilling JD; Machkovech HM; Kim AH; Schwendener R; Schaffer JE
    Am J Physiol Heart Circ Physiol; 2012 Dec; 303(11):H1366-73. PubMed ID: 23042950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ca2+-independent alterations in diastolic sarcomere length and relaxation kinetics in a mouse model of lipotoxic diabetic cardiomyopathy.
    Flagg TP; Cazorla O; Remedi MS; Haim TE; Tones MA; Bahinski A; Numann RE; Kovacs A; Schaffer JE; Nichols CG; Nerbonne JM
    Circ Res; 2009 Jan; 104(1):95-103. PubMed ID: 19023131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein B production reduces lipotoxic cardiomyopathy: studies in heart-specific lipoprotein lipase transgenic mouse.
    Yokoyama M; Yagyu H; Hu Y; Seo T; Hirata K; Homma S; Goldberg IJ
    J Biol Chem; 2004 Feb; 279(6):4204-11. PubMed ID: 14634011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A murine model of isolated cardiac steatosis leads to cardiomyopathy.
    Glenn DJ; Wang F; Nishimoto M; Cruz MC; Uchida Y; Holleran WM; Zhang Y; Yeghiazarians Y; Gardner DG
    Hypertension; 2011 Feb; 57(2):216-22. PubMed ID: 21220706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice.
    Lee Y; Naseem RH; Duplomb L; Park BH; Garry DJ; Richardson JA; Schaffer JE; Unger RH
    Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13624-9. PubMed ID: 15347805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart.
    Fentzke RC; Korcarz CE; Lang RM; Lin H; Leiden JM
    J Clin Invest; 1998 Jun; 101(11):2415-26. PubMed ID: 9616213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and Cardiac Adaptation to Chronic Pharmacologic Blockade of Facilitative Glucose Transport in Murine Dilated Cardiomyopathy and Myocardial Ischemia.
    Heitmeier MR; Payne MA; Weinheimer C; Kovacs A; Hresko RC; Jay PY; Hruz PW
    Sci Rep; 2018 Apr; 8(1):6475. PubMed ID: 29691457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac lipid accumulation associated with diastolic dysfunction in obese mice.
    Christoffersen C; Bollano E; Lindegaard ML; Bartels ED; Goetze JP; Andersen CB; Nielsen LB
    Endocrinology; 2003 Aug; 144(8):3483-90. PubMed ID: 12865329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin expression in cardiomyocytes induces dilated cardiomyopathy.
    Renault MA; Robbesyn F; Réant P; Douin V; Daret D; Allières C; Belloc I; Couffinhal T; Arnal JF; Klingel K; Desgranges C; Dos Santos P; Charpentier F; Gadeau AP
    Circ Heart Fail; 2010 May; 3(3):431-9. PubMed ID: 20200330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy.
    Wessely R; Klingel K; Santana LF; Dalton N; Hongo M; Jonathan Lederer W; Kandolf R; Knowlton KU
    J Clin Invest; 1998 Oct; 102(7):1444-53. PubMed ID: 9769337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase-D1 overexpression prevents lipid-induced cardiac insulin resistance.
    Dirkx E; van Eys GJ; Schwenk RW; Steinbusch LK; Hoebers N; Coumans WA; Peters T; Janssen BJ; Brans B; Vogg AT; Neumann D; Glatz JF; Luiken JJ
    J Mol Cell Cardiol; 2014 Nov; 76():208-17. PubMed ID: 25173922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragalus polysaccharides repress myocardial lipotoxicity in a PPARalpha-dependent manner in vitro and in vivo in mice.
    Chen W; Lai Y; Wang L; Xia Y; Chen W; Zhao X; Yu M; Li Y; Zhang Y; Ye H
    J Diabetes Complications; 2015 Mar; 29(2):164-75. PubMed ID: 25499591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiposity of the heart, revisited.
    McGavock JM; Victor RG; Unger RH; Szczepaniak LS;
    Ann Intern Med; 2006 Apr; 144(7):517-24. PubMed ID: 16585666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway.
    Pellieux C; Aasum E; Larsen TS; Montessuit C; Papageorgiou I; Pedrazzini T; Lerch R
    J Mol Cell Cardiol; 2006 Sep; 41(3):459-66. PubMed ID: 16859699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanistic role for cardiac myocyte apoptosis in heart failure.
    Wencker D; Chandra M; Nguyen K; Miao W; Garantziotis S; Factor SM; Shirani J; Armstrong RC; Kitsis RN
    J Clin Invest; 2003 May; 111(10):1497-504. PubMed ID: 12750399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus.
    Finck BN; Lehman JJ; Leone TC; Welch MJ; Bennett MJ; Kovacs A; Han X; Gross RW; Kozak R; Lopaschuk GD; Kelly DP
    J Clin Invest; 2002 Jan; 109(1):121-30. PubMed ID: 11781357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.